Literature DB >> 18159896

Genetic mutations involved in melanoma: a summary of our current understanding.

Whitney A High1, William A Robinson.   

Abstract

The biomolecular understanding of melanoma is in flux. The importance of high-penetrance genes involved in familial melanoma includes a significant number of mutations that directly lead to impairment of the checkpoints of the normal cell cycle. Furthermore, a greater understanding of the interaction between genetic factors and environmental factors, such as MC1R, CDKN2A, BRAF, and ultraviolet light, is emerging from landmark research. Although currently and with rare exception most clinicians still confine genetic testing to the realm of research, even in familial melanoma, continued and major advances in this arena may lead to development of new and revolutionary means of diagnosis and treatment, patterned on improved understanding of melanoma-related genetic mutations and resultant aberrations in cellular pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18159896     DOI: 10.1016/j.yadr.2007.07.009

Source DB:  PubMed          Journal:  Adv Dermatol        ISSN: 0882-0880


  7 in total

Review 1.  Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).

Authors:  Jun Guo; Shukui Qin; Jun Liang; Tongyu Lin; Lu Si; Xiaohong Chen; Zhihong Chi; Chuanliang Cui; Nan Du; Yun Fan; Kangsheng Gu; Fang Li; Junling Li; Yongheng Li; Houjie Liang; Jiwei Liu; Man Lu; Aiping Lu; Kejun Nan; Xiaohui Niu; Hongming Pan; Guoxin Ren; Xiubao Ren; Yongqian Shu; Xin Song; Min Tao; Baocheng Wang; Wenbin Wei; Di Wu; Lingying Wu; Aiwen Wu; Xiaolin Xu; Junyi Zhang; Xiaoshi Zhang; Yiping Zhang; Huiyan Zhu
Journal:  Ann Transl Med       Date:  2015-12

2.  Pro-prion binds filamin A, facilitating its interaction with integrin beta1, and contributes to melanomagenesis.

Authors:  Chaoyang Li; Shuiliang Yu; Fumihiko Nakamura; Olli T Pentikäinen; Neena Singh; Shaoman Yin; Wei Xin; Man-Sun Sy
Journal:  J Biol Chem       Date:  2010-07-21       Impact factor: 5.157

3.  Investigation of skin self-examination and sunscreen use in adolescents in northern Cyprus.

Authors:  Didem Mullaaziz; Aslı Kaptanoğlu; Evren Hınçal; Emel Erdal Çalıkoğlu
Journal:  Postepy Dermatol Alergol       Date:  2021-07-26       Impact factor: 1.837

4.  A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial.

Authors:  Tianhong Li; Scott D Christensen; Paul H Frankel; Kim A Margolin; Sanjiv S Agarwala; Thehang Luu; Philip C Mack; Primo N Lara; David R Gandara
Journal:  Invest New Drugs       Date:  2010-10-22       Impact factor: 3.850

5.  Relationship Between LAPTM4B Gene Polymorphism and Susceptibility of Malignant Melanoma in Chinese Patients.

Authors:  Meng Zhang; Rouli Zhou; Jianjun Xu; Qingyun Zhang
Journal:  Transl Oncol       Date:  2014-10-24       Impact factor: 4.243

6.  MIST1 regulates SNAI1 and acts through the PTEN/AKT signaling axis to promote anoikisresistance in human melanoma cells.

Authors:  Yiju Lee; Weifeng Yao; Chunjun Yang; Yunrui Li; Haiyang Ni; Lei Wang; Bin Ji; Yongge Gu; Sen Yang
Journal:  Exp Ther Med       Date:  2018-05-29       Impact factor: 2.447

7.  Giant congenital nodular melanoma in a newborn: a case report and literature review.

Authors:  Jun Zhou; Meng-Xing Lv; Ling Duan; Yu-Cheng Xie; Zhi-Xiang A; Hong-Fang Wu; Yan Gao
Journal:  BMC Pediatr       Date:  2021-03-11       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.